05-29-2007: Eurofins Medigenomix GmbH / MWG Biotech AG have finalised a genome sequencing project with Wacker Chemie AG for the analysis of the genetic differences between Wacker's proprietary industrial protein production E. coli strain and its corresponding parental strain. The successful sequencing is an important step to further improve and advance Wacker's E.coli strain and the related proprietary E. coli secretion system, which is a well-established technology for cost-efficient production of proteins.
The genome of the E.coli strain was sequenced with ultra parallel shotgun sequencing using GS 20 technology, a high-throughput automated DNA sequencing system. The sequence reads have been assembled into contigs, i.e. sets of overlapping DNA segments, and subsequently analysed with MWG's proprietary genome comparison tool and displayed with the MWG's Annotation Viewer software.
"We are very impressed by the rapid and precise analysis of our E. coli production strain. The results will help us to further improve the performance of our production strain immensely", states Günter Wich, Head of the Biotechnology Department of Wacker Chemie AG's corporate R&D. "In addition, the further increase of efficiency will result in even more favourable cost of goods which we can offer to our customers. This is a key advantage over conventional protein production systems."
Wacker's E. coli secretion system is a commercialized and well-established technology for protein production. The core of the technology is Wacker's proprietary E. coli K12 strain, which is capable
of secreting a vast variety of different recombinant proteins in their native form into the fermentation broth during cultivation, according to the company.
Watchlist
This is where you can add this news to your personal favourites
Eurofins Medigenomix GmbH / MWG Biotech AG have finalised a genome sequencing project with Wacker Chemie AG for the analysis of the genetic differences between Wacker's proprietary industrial protein production E. coli strain and its corresponding parental strain. The successful sequencing ... more
With the new fully automated lab robot
RoboSeq 2500 DT Disposable Tips, MWG-Biotech announces the official
commercialization of the latest member of its successful series of
Automated Biosystems. The new system was officially launched on
Biotechnica in Hanover at the beginning of Octobe ... more
Pan® Oligo Sets is the brand name for MWG-Biotech’s new
oligonucleotide sets that enable customers to produce their own
oligonucleotide microarrays (DNA chips). The sets are based on the
competence and the success of MWG-Biotech’s Pan® Array series of
catalogue DNA chips and on the high ... more
MWG Biotech is an international provider of genomics products and services in DNA Oligonucleotide Synthesis, siRNA Synthesis, and DNA Sequencing. With strong customer orientientation, fast, web-based service and high quality products we provide the basis for success in the life sciences for ... more
More about Wacker Chemie
ContactWacker Chemie AG
Hanns-Seidel-Platz 4
81737 München
DEUTSCHLAND
As part of a constant sales channel improvement, Wacker is restructuring its distribution network in Russia. Effective February 2012, the chemical distributor Eurohim will handle WACKER’s dispersions and dispersible powders for the construction industry, marketed under the VINNAPAS® brand. ... more
Wacker, the Munich-based chemicals group, is deepening its ties with Siliconas Silam S.A., a silicones compounder in Spain. The two companies recently signed an agreement to that effect. Under its terms, Siliconas Silam may sell ready-to-use products made from Wacker silicone rubber base un ... more
In fiscal 2011, Wacker Chemie AG continued to increase its sales compared to the prior year. According to preliminary calculations, the Munich-based chemical company achieved total sales of €4.91 billion in 2011 (2010: €4.75 billion), up over 3 percent year over year. This slight sales rise ... more
WACKER is a globally operating chemical company headquartered in Munich, Germany. Its portfolio focuses on silicone chemistry, polymer chemistry, fine chemicals and biotech products, polysilicon, wafers and hyperpure silicon monocrystals. In line with these core areas of expertise, WACKER h ... more
Eurofins Scientific announces the successful closing of the transaction for a 67% majority stake in each of the two subsidiaries of the Fondation Institut Pasteur de Lille (IPL), namely IPL Invest and IPL Santé Environnement Durable Nord (IPL SED Nord), on the 31st of October, 2011.
As prev ... more
Following the signing of an exclusive discussion agreement with the Fondation Institut Pasteur de Lille (IPL), Eurofins Scientific announced that it has signed a definitive, mutually-binding agreement on to acquire a 67% stake in each of its two subsidiaries, namely IPL Invest and IPL Santé ... more
Eurofins Scientific inaugurated a 3,000 m2 extension to its laboratory in Nantes, France. The extension was completed in early summer and turns Eurofins Nantes into the largest single-site independent food testing laboratory in the world, with 11,500 m2 total laboratory surface and capacity ... more
With about US$ 800 million annual sales and more than 7000 employees over 150 sites in 29 countries, Eurofins Scientific is a leading international group of laboratories providing an unparalleled range of testing and support services to the pharmaceutical, food, environmental and consumer p ... more
The GfA was founded in 1985 and is today one of Europe’s leading institutes for environmental and food analyses as well as for emission and ambient air measurements, accidental release and workplace analyses. The GfA is one of the top 5 laboratories in the world and performed more than 7,00 ... more
Eurofins Scientific was founded in 1987 to market the SNIF-NMR technology, a patented analytical method used to verify the origin and purity of several types of food and beverages in cases where traditional testing methods would fail to detect a sophisticated fraud. Within a 20-year period, ... more
Wacker is strengthening its biopharmaceutical operations in Jena, Germany. The Munich-based chemical Group is investing around EUR15 million in this undertaking, which involves the GMP expansion of its Jena production facility and the construction of a new building there for process develop ... more
Eurofins Medigenomix GmbH / MWG Biotech AG have finalised a genome sequencing project with Wacker Chemie AG for the analysis of the genetic differences between Wacker's proprietary industrial protein production E. coli strain and its corresponding parental strain. The successful sequencing ... more